標(biāo)題: Titlebook: Recombinant Protein Drugs; Peter Buckel Book 2001 Birkh?user Verlag 2001 clinic.clinical trial.development.drug.drug discovery.drugs.futur [打印本頁] 作者: graphic 時(shí)間: 2025-3-21 17:04
書目名稱Recombinant Protein Drugs影響因子(影響力)
書目名稱Recombinant Protein Drugs影響因子(影響力)學(xué)科排名
書目名稱Recombinant Protein Drugs網(wǎng)絡(luò)公開度
書目名稱Recombinant Protein Drugs網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Recombinant Protein Drugs被引頻次
書目名稱Recombinant Protein Drugs被引頻次學(xué)科排名
書目名稱Recombinant Protein Drugs年度引用
書目名稱Recombinant Protein Drugs年度引用學(xué)科排名
書目名稱Recombinant Protein Drugs讀者反饋
書目名稱Recombinant Protein Drugs讀者反饋學(xué)科排名
作者: 有限 時(shí)間: 2025-3-21 22:57
lead to other problems. For example, if the compressor “l(fā)ocks-up”, the belt which connects the compressor to the engine may break and get caught in some of the moving parts of the engine. In essence, the importance of the compressor to the air conditioning system is like that of the heart to the hum作者: MIRE 時(shí)間: 2025-3-22 03:46 作者: Goblet-Cells 時(shí)間: 2025-3-22 06:22
Peter Hans Hofschneider,Kenneth Murrayons by the human operators. During the teaching mode, operation details are stored for future repetitive replays. Since human intervention is required, system autonomy is reduced. The other approach involves the use of textual programming. A system is given the assembly plan in terms of operation de作者: 重疊 時(shí)間: 2025-3-22 12:14 作者: Acclaim 時(shí)間: 2025-3-22 13:47 作者: DEMUR 時(shí)間: 2025-3-22 17:45 作者: nocturia 時(shí)間: 2025-3-22 23:40
Theodore Friedmannticipate and eliminate high risk or high cost production problems. The key to successful implementation of a producibility engineering program is a management committment to the allocation of sufficient resources to insure that design concepts have been subjected to thorough analyses before the desi作者: 轉(zhuǎn)向 時(shí)間: 2025-3-23 04:12 作者: plasma 時(shí)間: 2025-3-23 06:15 作者: anarchist 時(shí)間: 2025-3-23 13:34 作者: TIA742 時(shí)間: 2025-3-23 15:58
2296-6056 ical industry. In addition, scientists from basic research, clinic and industry actively involved in new developments discuss...978-3-0348-9527-9978-3-0348-8346-7Series ISSN 2296-6056 Series E-ISSN 2296-6064 作者: 油氈 時(shí)間: 2025-3-23 21:34
978-3-0348-9527-9Birkh?user Verlag 2001作者: filial 時(shí)間: 2025-3-23 23:18
Recombinant Protein Drugs978-3-0348-8346-7Series ISSN 2296-6056 Series E-ISSN 2296-6064 作者: 口味 時(shí)間: 2025-3-24 02:40 作者: 音樂戲劇 時(shí)間: 2025-3-24 08:43 作者: 誘拐 時(shí)間: 2025-3-24 12:47
Combining science and business: from recombinant DNA to vaccines against hepatitis B virusthat had been formed two years previously and in which INCO had been a significant and well satisfied corporate investor. How about a European analogue? After two fascinating if rather surrealistic days we all agreed to take the matter further at a second meeting in Paris a few weeks later.作者: Cardiac-Output 時(shí)間: 2025-3-24 16:18 作者: nostrum 時(shí)間: 2025-3-24 21:43
Clotting factors VIII and IXins in the clotting cascade [1] (Fig. 1). The hallmark of severe haemophilia is recurrent and spontaneous haemarthrosis, typically affecting the hinge joints such as the ankle, knee and elbow. The severity of bleeding depends upon the level of factor in the blood.作者: 遺留之物 時(shí)間: 2025-3-25 02:41
Designing immunocytokines: genetically engineered fusion proteins for targeted immune therapyby replacing the use of animals altogether. The latter approaches involve the use of phage display or . molecular evolution technologies that use antigen binding selection coupled with linked gene sequence identification to isolate binding proteins and their coding sequences from enormously complex mixtures of randomly generated molecules.作者: 網(wǎng)絡(luò)添麻煩 時(shí)間: 2025-3-25 06:31 作者: obeisance 時(shí)間: 2025-3-25 08:34
Recombinant interferon - the 20th anniversarymouse IFN and of the control of its expression, it became evident that cloning of the chromosomal IFN gene would lead to a wealth of information unattainable by any other means. Moreover, the undertaking was a challenge, since pure IFN was extremely hard to come by, its structure was unknown and wou作者: Obedient 時(shí)間: 2025-3-25 12:34 作者: promote 時(shí)間: 2025-3-25 18:53 作者: Harpoon 時(shí)間: 2025-3-25 23:31 作者: 吞下 時(shí)間: 2025-3-26 02:11 作者: commute 時(shí)間: 2025-3-26 05:48 作者: Fatten 時(shí)間: 2025-3-26 08:33
Improving protein therapeutics: the evolution of the modern pharmacopoeia number in the hundreds [1, 2] and include monoclonal antibodies, growth factors, cytokines, soluble receptors, hormones and proteins to block the function of a variety of infectious agents. Proteins are specific, exert their effects at low concentrations, and their virtually limitless number enable作者: 確保 時(shí)間: 2025-3-26 13:37
Principles of gene transfer and foreign protein expression for human gene therapyl development of efficient and targeted vectors to deliver therapeutic foreign genetic elements into defective cells for the purpose of complementing underlying genetic defects responsible for human genetic disease. The initial models for this approach were the single-gene Mendelian defects associat作者: 冒號(hào) 時(shí)間: 2025-3-26 20:53
Book 2001em belonging to the most successful pharmaceutical products. More than thirty different proteins are available for a variety of clinical applications, over 300 proteins are presently being evaluated in clinical trials. In this new volume of the MDT series, historical, technical and clinical aspects 作者: 經(jīng)典 時(shí)間: 2025-3-27 00:31
2296-6056 some of them belonging to the most successful pharmaceutical products. More than thirty different proteins are available for a variety of clinical applications, over 300 proteins are presently being evaluated in clinical trials. In this new volume of the MDT series, historical, technical and clinica作者: 背信 時(shí)間: 2025-3-27 03:58
Colony-stimulating factors: altering the practice of oncologyally mature blood cells. The control of haematopoiesis and the migration and functional activation of blood cells are closely controlled by stimulatory and inhibitory effects of at least 25 regulatory factors known as haematopoietic growth factors or cytokines.作者: nutrients 時(shí)間: 2025-3-27 07:21
Improving protein therapeutics: the evolution of the modern pharmacopoeiaatients and physicians. These include low oral and transdermal bioavailabilities, which have necessitated their delivery by injections or infusions [3]. Moreover, injections must be given frequently because the half-lives of proteins are short (Tab.1).作者: 臆斷 時(shí)間: 2025-3-27 09:53
over 30 % of the share of the world market for automobile air-conditioner compressors. This accounts for more than 30 million compressor units, to date. Ten types of compressors have been manufactured in TAL since 1976. Although there have been several minor model modifications for the different se作者: 沐浴 時(shí)間: 2025-3-27 14:06
over 30 % of the share of the world market for automobile air-conditioner compressors. This accounts for more than 30 million compressor units, to date. Ten types of compressors have been manufactured in TAL since 1976. Although there have been several minor model modifications for the different se作者: 不開心 時(shí)間: 2025-3-27 19:45
Charles Weissmann over 30 % of the share of the world market for automobile air-conditioner compressors. This accounts for more than 30 million compressor units, to date. Ten types of compressors have been manufactured in TAL since 1976. Although there have been several minor model modifications for the different se作者: 凹槽 時(shí)間: 2025-3-28 01:26 作者: 蚊子 時(shí)間: 2025-3-28 03:02
im has been due to the fact that many expert system applications inevitably have to reason about uncertain knowledge, and that the resolution principle cannot handle that kind of information. Indeed, there have been only few attempts to extend the application of theorem proving techniques and full c作者: evaculate 時(shí)間: 2025-3-28 07:20 作者: instructive 時(shí)間: 2025-3-28 12:54 作者: fatuity 時(shí)間: 2025-3-28 15:28
Theodore Friedmannation lies in a life-cycle approach to product development and manufacture. The cost considerations must begin upon initiation of the system design process and continue through the development process. One cost control method which is recieving increasing emphasis is Producibility Engineering. Produ作者: 挖掘 時(shí)間: 2025-3-28 22:38 作者: 鍵琴 時(shí)間: 2025-3-28 23:18